FEED.US ENvue Medical Inc.

Healthcare Medical Devices USA Stocks
0.3780 USD
Close of Nov 14, 2026
0.1210 73.08
Market cap
USD 349K
P/E
-
P/B
0.01x
ROE
-56.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is FEED.US undervalued?

Graham number

The Graham number of ENvue Medical Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ENvue Medical Inc. fundamental analysis

No fundamental analysis for ENvue Medical Inc. yet.

ENvue Medical Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ENvue Medical Inc.

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinar…

Full company profile